Outcome of hospitalised heart failure in Japan and the United Kingdom stratified by plasma N-terminal pro-B-type natriuretic peptide

[1] Ambrosy AP(2014)The global health and economic burden of hospitalizations for heart failure: lessons learned from HHF registries J Am Coll Cardiol 63 1123-1133

[2] Fonarow GC(2017)Epidemiology of heart failure in Germany: a retrospective database study Clin Res Cardiol 106 913-922

[3] Butler J(2013)2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 e147-e239

[4] Chioncel O(2016)2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur Heart J 37 2129-2200

[5] Greene SJ(2013)Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF) Circ Cardiovasc Qual Outcomes 6 534-542

[6] Vaduganathan M(2014)International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial Eur J Heart Fail 16 614-624

[7] Nodari S(2015)Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial Eur J Heart Fail 17 591-600

[8] Lam CS(2015)Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial Circulation 131 34-42

[9] Sato N(2016)Geographic variations in the PARADIGM-HF heart failure trial Eur Heart J 37 3167-3174

[10] Shah AN(2015)International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction Circulation 131 43-53

[1] Ambrosy AP(2014)The global health and economic burden of hospitalizations for heart failure: lessons learned from HHF registries J Am Coll Cardiol 63 1123-1133

[2] Fonarow GC(2017)Epidemiology of heart failure in Germany: a retrospective database study Clin Res Cardiol 106 913-922

[3] Butler J(2013)2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 62 e147-e239

[4] Chioncel O(2016)2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC Eur Heart J 37 2129-2200

[5] Greene SJ(2013)Global variation in quality of care among patients hospitalized with acute heart failure in an international trial: findings from the acute study clinical effectiveness of nesiritide in decompensated heart failure trial (ASCEND-HF) Circ Cardiovasc Qual Outcomes 6 534-542

[6] Vaduganathan M(2014)International differences in clinical characteristics, management, and outcomes in acute heart failure patients: better short-term outcomes in patients enrolled in Eastern Europe and Russia in the PROTECT trial Eur J Heart Fail 16 614-624

[7] Nodari S(2015)Global variation in clinical profile, management, and post-discharge outcomes among patients hospitalized for worsening chronic heart failure: findings from the ASTRONAUT trial Eur J Heart Fail 17 591-600

[8] Lam CS(2015)Regional variation in patients and outcomes in the treatment of preserved cardiac function heart failure with an aldosterone antagonist (TOPCAT) trial Circulation 131 34-42

[9] Sato N(2016)Geographic variations in the PARADIGM-HF heart failure trial Eur Heart J 37 3167-3174

[10] Shah AN(2015)International geographic variation in event rates in trials of heart failure with preserved and reduced ejection fraction Circulation 131 43-53